Hairloss.
Conditions
Interventions
Intervention 1: Intervention group: Participants in the intervention group will receive a daily standard dose of creatine supplement. This dosage is determined based on common and safe guidelines for
Sponsors
the Iran Center for Dermatology and Hair Research.
Eligibility
Sex/Gender
Male
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: General Health Status: Healthy individuals without chronic diseases or metabolic disorders. Male Pattern Baldness: Participants must not exhibit early signs of male pattern baldness (androgenetic alopecia). Sporting Activity: Individuals must have been regularly engaged in resistance training (e.g., bodybuilding) for at least one year. No Recent Supplement Use: Individuals must not have used any creatine supplements or hair loss-related medications (such as finasteride or minoxidil) for at least one month prior to the study.
Exclusion criteria
Exclusion criteria: History of Hair-Related Diseases: Individuals with skin diseases or other conditions that could affect hair loss, such as alopecia areata. Current Medication or Supplement Use: Current users of medications affecting hormones or other supplements related to hair loss. Advanced Hair Loss: Individuals with advanced hair loss (Norwood stage 5 or above), which could complicate study outcomes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair density based on counting the number of hair strands in a specific area of the scalp, using standard imaging techniques at different time points (before the intervention and three months after the intervention). Timepoint: before the intervention and three months after the intervention. Method of measurement: using standard imaging techniques. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in serum hormone levels: Measurement of changes in testosterone, dihydrotestosterone (DHT), and other related hormones at different time points throughout the study.Hair loss rate: Assessment of the extent of hair loss using standard imaging techniques in specific areas of the scalp, conducted at various time intervals before and after the intervention. Timepoint: After 3 months. Method of measurement: Use of standard imaging techniques/blood tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammadyasin Lak
the Iran Center for Dermatology and Hair Research.
Outcome results
None listed